nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Night blindness—Varenicline—nicotine dependence	0.0391	0.0581	CcSEcCtD
Acitretin—Cataract subcapsular—Varenicline—nicotine dependence	0.0353	0.0525	CcSEcCtD
Acitretin—RBP1—Retinoid metabolism and transport—AKR1B10—nicotine dependence	0.026	0.193	CbGpPWpGaD
Acitretin—RBP1—cardiovascular system—nicotine dependence	0.0258	0.134	CbGeAlD
Acitretin—Peripheral ischaemia—Varenicline—nicotine dependence	0.0253	0.0375	CcSEcCtD
Acitretin—RXRG—cardiovascular system—nicotine dependence	0.0234	0.122	CbGeAlD
Acitretin—CYP26A1—brain—nicotine dependence	0.0212	0.11	CbGeAlD
Acitretin—RBP1—midbrain—nicotine dependence	0.0202	0.105	CbGeAlD
Acitretin—RXRG—midbrain—nicotine dependence	0.0182	0.0949	CbGeAlD
Acitretin—Urine abnormality—Varenicline—nicotine dependence	0.0166	0.0247	CcSEcCtD
Acitretin—Urine analysis abnormal—Varenicline—nicotine dependence	0.0157	0.0233	CcSEcCtD
Acitretin—Vaginal discharge—Varenicline—nicotine dependence	0.0151	0.0225	CcSEcCtD
Acitretin—Psoriasis—Varenicline—nicotine dependence	0.0147	0.0218	CcSEcCtD
Acitretin—CYP26A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0145	0.108	CbGpPWpGaD
Acitretin—CYP26A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0143	0.106	CbGpPWpGaD
Acitretin—Cyst—Varenicline—nicotine dependence	0.0138	0.0205	CcSEcCtD
Acitretin—RBP1—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.0133	0.0983	CbGpPWpGaD
Acitretin—Suicidal ideation—Varenicline—nicotine dependence	0.0131	0.0195	CcSEcCtD
Acitretin—RXRA—brain—nicotine dependence	0.0131	0.0679	CbGeAlD
Acitretin—Hyperlipidaemia—Varenicline—nicotine dependence	0.0128	0.019	CcSEcCtD
Acitretin—RBP1—brain—nicotine dependence	0.0127	0.066	CbGeAlD
Acitretin—Scotoma—Varenicline—nicotine dependence	0.0121	0.018	CcSEcCtD
Acitretin—Fungal infection—Varenicline—nicotine dependence	0.0119	0.0177	CcSEcCtD
Acitretin—CYP26A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0118	0.0872	CbGpPWpGaD
Acitretin—Gingivitis—Varenicline—nicotine dependence	0.0117	0.0174	CcSEcCtD
Acitretin—RARB—brain—nicotine dependence	0.0117	0.061	CbGeAlD
Acitretin—RXRG—brain—nicotine dependence	0.0115	0.0596	CbGeAlD
Acitretin—Glycosuria—Varenicline—nicotine dependence	0.0114	0.0169	CcSEcCtD
Acitretin—Dysphonia—Varenicline—nicotine dependence	0.0112	0.0166	CcSEcCtD
Acitretin—Acne—Varenicline—nicotine dependence	0.0109	0.0163	CcSEcCtD
Acitretin—Eye irritation—Varenicline—nicotine dependence	0.0108	0.016	CcSEcCtD
Acitretin—RXRB—brain—nicotine dependence	0.0108	0.0561	CbGeAlD
Acitretin—RARG—brain—nicotine dependence	0.00956	0.0498	CbGeAlD
Acitretin—RARA—brain—nicotine dependence	0.00899	0.0468	CbGeAlD
Acitretin—Salivary hypersecretion—Varenicline—nicotine dependence	0.00895	0.0133	CcSEcCtD
Acitretin—Influenza like illness—Varenicline—nicotine dependence	0.00895	0.0133	CcSEcCtD
Acitretin—Photophobia—Varenicline—nicotine dependence	0.00865	0.0129	CcSEcCtD
Acitretin—Dry eye—Varenicline—nicotine dependence	0.00851	0.0126	CcSEcCtD
Acitretin—Oesophagitis—Varenicline—nicotine dependence	0.00842	0.0125	CcSEcCtD
Acitretin—Mouth ulceration—Varenicline—nicotine dependence	0.00833	0.0124	CcSEcCtD
Acitretin—Hypertonia—Varenicline—nicotine dependence	0.00808	0.012	CcSEcCtD
Acitretin—Diabetes mellitus—Varenicline—nicotine dependence	0.00769	0.0114	CcSEcCtD
Acitretin—Deafness—Varenicline—nicotine dependence	0.00748	0.0111	CcSEcCtD
Acitretin—Eczema—Varenicline—nicotine dependence	0.00744	0.0111	CcSEcCtD
Acitretin—Eye pain—Varenicline—nicotine dependence	0.00741	0.011	CcSEcCtD
Acitretin—Libido decreased—Varenicline—nicotine dependence	0.00721	0.0107	CcSEcCtD
Acitretin—Hot flush—Varenicline—nicotine dependence	0.00715	0.0106	CcSEcCtD
Acitretin—Increased appetite—Varenicline—nicotine dependence	0.00712	0.0106	CcSEcCtD
Acitretin—Menopausal symptoms—Varenicline—nicotine dependence	0.00709	0.0105	CcSEcCtD
Acitretin—Visual disturbance—Varenicline—nicotine dependence	0.00706	0.0105	CcSEcCtD
Acitretin—Thirst—Varenicline—nicotine dependence	0.00703	0.0104	CcSEcCtD
Acitretin—Arthritis—Varenicline—nicotine dependence	0.00688	0.0102	CcSEcCtD
Acitretin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00683	0.0101	CcSEcCtD
Acitretin—Osteoarthritis—Varenicline—nicotine dependence	0.00669	0.00994	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00664	0.00986	CcSEcCtD
Acitretin—CYP26A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00663	0.0492	CbGpPWpGaD
Acitretin—Migraine—Varenicline—nicotine dependence	0.00658	0.00978	CcSEcCtD
Acitretin—CYP26A1—Biological oxidations—CYP2A7—nicotine dependence	0.00625	0.0463	CbGpPWpGaD
Acitretin—Liver function test abnormal—Varenicline—nicotine dependence	0.00617	0.00917	CcSEcCtD
Acitretin—CYP26A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00616	0.0457	CbGpPWpGaD
Acitretin—Dry skin—Varenicline—nicotine dependence	0.00613	0.00911	CcSEcCtD
Acitretin—Gastritis—Varenicline—nicotine dependence	0.00592	0.00879	CcSEcCtD
Acitretin—RXRA—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00539	0.04	CbGpPWpGaD
Acitretin—Erectile dysfunction—Varenicline—nicotine dependence	0.00532	0.00791	CcSEcCtD
Acitretin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00528	0.00784	CcSEcCtD
Acitretin—Weight increased—Varenicline—nicotine dependence	0.00526	0.00782	CcSEcCtD
Acitretin—Depression—Varenicline—nicotine dependence	0.00514	0.00764	CcSEcCtD
Acitretin—ALB—brain—nicotine dependence	0.00507	0.0264	CbGeAlD
Acitretin—Stomatitis—Varenicline—nicotine dependence	0.00502	0.00746	CcSEcCtD
Acitretin—Conjunctivitis—Varenicline—nicotine dependence	0.00501	0.00744	CcSEcCtD
Acitretin—Epistaxis—Varenicline—nicotine dependence	0.00486	0.00722	CcSEcCtD
Acitretin—Sinusitis—Varenicline—nicotine dependence	0.00484	0.00718	CcSEcCtD
Acitretin—Hypoaesthesia—Varenicline—nicotine dependence	0.0046	0.00684	CcSEcCtD
Acitretin—Oedema peripheral—Varenicline—nicotine dependence	0.00456	0.00677	CcSEcCtD
Acitretin—Visual impairment—Varenicline—nicotine dependence	0.00446	0.00663	CcSEcCtD
Acitretin—RXRA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00437	0.0324	CbGpPWpGaD
Acitretin—Eye disorder—Varenicline—nicotine dependence	0.00432	0.00642	CcSEcCtD
Acitretin—Tinnitus—Varenicline—nicotine dependence	0.00431	0.00641	CcSEcCtD
Acitretin—Angiopathy—Varenicline—nicotine dependence	0.0042	0.00624	CcSEcCtD
Acitretin—Immune system disorder—Varenicline—nicotine dependence	0.00418	0.00621	CcSEcCtD
Acitretin—Chills—Varenicline—nicotine dependence	0.00415	0.00617	CcSEcCtD
Acitretin—Erythema—Varenicline—nicotine dependence	0.00403	0.00598	CcSEcCtD
Acitretin—Dysgeusia—Varenicline—nicotine dependence	0.00394	0.00586	CcSEcCtD
Acitretin—Back pain—Varenicline—nicotine dependence	0.0039	0.00579	CcSEcCtD
Acitretin—Muscle spasms—Varenicline—nicotine dependence	0.00387	0.00575	CcSEcCtD
Acitretin—Vision blurred—Varenicline—nicotine dependence	0.0038	0.00564	CcSEcCtD
Acitretin—Ill-defined disorder—Varenicline—nicotine dependence	0.00374	0.00555	CcSEcCtD
Acitretin—Angioedema—Varenicline—nicotine dependence	0.00368	0.00547	CcSEcCtD
Acitretin—Malaise—Varenicline—nicotine dependence	0.00363	0.0054	CcSEcCtD
Acitretin—Cough—Varenicline—nicotine dependence	0.00351	0.00522	CcSEcCtD
Acitretin—RXRA—Orphan transporters—GABRA4—nicotine dependence	0.00347	0.0257	CbGpPWpGaD
Acitretin—Arthralgia—Varenicline—nicotine dependence	0.00343	0.0051	CcSEcCtD
Acitretin—Chest pain—Varenicline—nicotine dependence	0.00343	0.0051	CcSEcCtD
Acitretin—Myalgia—Varenicline—nicotine dependence	0.00343	0.0051	CcSEcCtD
Acitretin—Anxiety—Varenicline—nicotine dependence	0.00342	0.00508	CcSEcCtD
Acitretin—Discomfort—Varenicline—nicotine dependence	0.00339	0.00503	CcSEcCtD
Acitretin—Dry mouth—Varenicline—nicotine dependence	0.00335	0.00498	CcSEcCtD
Acitretin—Oedema—Varenicline—nicotine dependence	0.00329	0.00488	CcSEcCtD
Acitretin—Infection—Varenicline—nicotine dependence	0.00327	0.00485	CcSEcCtD
Acitretin—Skin disorder—Varenicline—nicotine dependence	0.00319	0.00474	CcSEcCtD
Acitretin—Hyperhidrosis—Varenicline—nicotine dependence	0.00318	0.00472	CcSEcCtD
Acitretin—Anorexia—Varenicline—nicotine dependence	0.00313	0.00466	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00299	0.00445	CcSEcCtD
Acitretin—Insomnia—Varenicline—nicotine dependence	0.00297	0.00442	CcSEcCtD
Acitretin—Somnolence—Varenicline—nicotine dependence	0.00292	0.00434	CcSEcCtD
Acitretin—Dyspepsia—Varenicline—nicotine dependence	0.00289	0.0043	CcSEcCtD
Acitretin—Decreased appetite—Varenicline—nicotine dependence	0.00286	0.00425	CcSEcCtD
Acitretin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00284	0.00422	CcSEcCtD
Acitretin—Fatigue—Varenicline—nicotine dependence	0.00283	0.00421	CcSEcCtD
Acitretin—Constipation—Varenicline—nicotine dependence	0.00281	0.00418	CcSEcCtD
Acitretin—Pain—Varenicline—nicotine dependence	0.00281	0.00418	CcSEcCtD
Acitretin—Feeling abnormal—Varenicline—nicotine dependence	0.00271	0.00403	CcSEcCtD
Acitretin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00269	0.00399	CcSEcCtD
Acitretin—Urticaria—Varenicline—nicotine dependence	0.00261	0.00388	CcSEcCtD
Acitretin—Abdominal pain—Varenicline—nicotine dependence	0.0026	0.00386	CcSEcCtD
Acitretin—Body temperature increased—Varenicline—nicotine dependence	0.0026	0.00386	CcSEcCtD
Acitretin—Hypersensitivity—Varenicline—nicotine dependence	0.00242	0.0036	CcSEcCtD
Acitretin—Asthenia—Varenicline—nicotine dependence	0.00236	0.0035	CcSEcCtD
Acitretin—Pruritus—Varenicline—nicotine dependence	0.00233	0.00346	CcSEcCtD
Acitretin—RXRA—Biological oxidations—CYP2A7—nicotine dependence	0.00232	0.0172	CbGpPWpGaD
Acitretin—Diarrhoea—Varenicline—nicotine dependence	0.00225	0.00334	CcSEcCtD
Acitretin—Dizziness—Varenicline—nicotine dependence	0.00217	0.00323	CcSEcCtD
Acitretin—Vomiting—Varenicline—nicotine dependence	0.00209	0.00311	CcSEcCtD
Acitretin—Rash—Varenicline—nicotine dependence	0.00207	0.00308	CcSEcCtD
Acitretin—Dermatitis—Varenicline—nicotine dependence	0.00207	0.00308	CcSEcCtD
Acitretin—Headache—Varenicline—nicotine dependence	0.00206	0.00306	CcSEcCtD
Acitretin—Nausea—Varenicline—nicotine dependence	0.00195	0.0029	CcSEcCtD
Acitretin—RARG—Gene Expression—CCAR1—nicotine dependence	0.00177	0.0131	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TAS2R16—nicotine dependence	0.0017	0.0126	CbGpPWpGaD
Acitretin—RBP1—Disease—AKR1B10—nicotine dependence	0.00168	0.0125	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—CCAR1—nicotine dependence	0.00162	0.012	CbGpPWpGaD
Acitretin—RARB—Gene Expression—CCAR1—nicotine dependence	0.00159	0.0118	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CCAR1—nicotine dependence	0.00152	0.0113	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CCAR1—nicotine dependence	0.00152	0.0113	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGD1—nicotine dependence	0.00134	0.0099	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKR1B10—nicotine dependence	0.00118	0.00874	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP2A7—nicotine dependence	0.00107	0.00793	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000848	0.00628	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—WASF2—nicotine dependence	0.000831	0.00616	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—WASF1—nicotine dependence	0.000797	0.00591	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CCAR1—nicotine dependence	0.000792	0.00587	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—OPRM1—nicotine dependence	0.000717	0.00532	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—DRD2—nicotine dependence	0.000519	0.00384	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2A7—nicotine dependence	0.000397	0.00294	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000387	0.00287	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2A7—nicotine dependence	0.000181	0.00134	CbGpPWpGaD
